COLTISHALL MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: D82062 | NORWICH, NR12 7HA
Showing results 101-150 of 648
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Memantine hydrochloride | 506 | 13.3K | £3.0K | +53.2% ▲ |
| Nitrofurantoin | 505 | 10.1K | £8.3K | +5.8% ▲ |
| Bumetanide | 503 | 18.1K | £2.0K | +84.6% ▲ |
| Esomeprazole | 492 | 17.2K | £1.5K | +21.6% ▲ |
| Flucloxacillin sodium | 476 | 19.1K | £1.5K | +5.9% ▲ |
| Sumatriptan succinate | 472 | 3,838 | £1.9K | +33.3% ▲ |
| Moxonidine | 469 | 19.2K | £2.9K | +742.5% ▲ |
| Trimethoprim | 469 | 10.5K | £714 | +129.5% ▲ |
| Loratadine | 462 | 19.2K | £450 | +121.1% ▲ |
| Digoxin | 457 | 12.4K | £921 | +20.8% ▲ |
| Promethazine hydrochloride | 457 | 15.3K | £2.3K | +27.9% ▲ |
| Carbocisteine | 452 | 56.7K | £1.6K | -15.3% ▼ |
| Nortriptyline | 451 | 23.2K | £1.7K | +210.0% ▲ |
| Carbamazepine | 446 | 64.4K | £2.9K | +50.3% ▲ |
| Codeine phosphate | 441 | 42.2K | £1.5K | -38.6% ▼ |
| Tiotropium bromide | 434 | 8,996 | £11.2K | +42.7% ▲ |
| Insulin aspart | 431 | 3,218 | £17.7K | +13.2% ▲ |
| Mebeverine hydrochloride | 424 | 30.2K | £1.3K | +36.6% ▲ |
| Progesterone | 422 | 31.1K | £5.6K | +0.8% vs avg |
| Hydrocortisone | 419 | 11.4K | £1.6K | -6.6% ▼ |
| Linagliptin | 418 | 7,217 | £8.0K | +2.1% ▲ |
| Mesalazine (Systemic) | 416 | 40.1K | £19.3K | +73.7% ▲ |
| Combined ethinylestradiol 30mcg | 413 | 27.8K | £1.3K | +48.7% ▲ |
| Hyoscine butylbromide | 407 | 32.9K | £2.5K | +74.6% ▲ |
| Cetirizine hydrochloride | 406 | 30.8K | £1.8K | -18.7% ▼ |
| Clarithromycin | 400 | 10.1K | £2.2K | +63.0% ▲ |
| 400 | 830 | £530 | +81.5% ▲ | |
| Betamethasone valerate | 399 | 31.8K | £1.9K | +3.6% ▲ |
| Nefopam hydrochloride | 398 | 28.4K | £2.9K | +251.9% ▲ |
| Clonazepam | 395 | 15.3K | £2.2K | +153.5% ▲ |
| 394 | 46.6K | £1.4K | +42.5% ▲ | |
| Beclometasone dipropionate | 391 | 414 | £1.3K | +81.8% ▲ |
| Ferrous sulfate | 390 | 10.3K | £355 | -24.2% ▼ |
| Oxybutynin | 378 | 17.3K | £1.2K | +98.4% ▲ |
| Hydroxychloroquine sulfate | 353 | 14.6K | £749 | +82.3% ▲ |
| Eprosartan | 338 | 8,862 | £3.9K | +1,574.0% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 338 | 26.4K | £1.6K | +49.6% ▲ |
| Hydroxocobalamin | 332 | 371 | £778 | -31.0% ▼ |
| Loperamide hydrochloride | 327 | 22.7K | £482 | +40.4% ▲ |
| Umeclidinium bromide/vilanterol | 325 | 325 | £9.9K | +66.7% ▲ |
| Etoricoxib | 321 | 9,975 | £2.5K | +298.4% ▲ |
| Nifedipine | 318 | 12.7K | £4.4K | +69.7% ▲ |
| Alfacalcidol | 318 | 10.7K | £1.7K | +157.1% ▲ |
| Bimatoprost | 318 | 3,069 | £2.7K | +113.9% ▲ |
| 317 | 2,935 | £812 | +51.7% ▲ | |
| Tamoxifen citrate | 310 | 9,540 | £1.1K | +276.4% ▲ |
| Lamotrigine | 300 | 16.2K | £897 | -49.2% ▼ |
| Dihydrocodeine tartrate | 299 | 23.9K | £1.6K | +53.1% ▲ |
| Phenoxymethylpenicillin (Penicillin V) | 295 | 21.5K | £1.1K | -3.7% ▼ |
| Sodium valproate | 293 | 39.4K | £4.3K | -7.9% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.